NEW ORLEANS, Louisiana — Prostate-specific antigen (PSA) is an imperfect screening biomarker for prostate cancer, but new data indicate that accounting for noncancer genetic factors that influence PSA ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- ...

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

Dear Dr. Roach: I am 65 and have been taking 5 mg of finasteride for over one year to address benign prostatic hyperplasia (BPH). My PSA score has lowered from 11.4 ng/mL (before finasteride) to 7.9 ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am 65 and have been taking 5 mg of finasteride for over ...

DEAR DR. ROACH: I am a 74-year-old male in relatively good health. The only prescribed medication I take is 5 mg of amlodipine daily. My issue is my PSA score. In 2004, I had a UTI, and the urologist ...

Saliva test which analyses genetic variants in DNA is better than the PSA blood test at assessing prostate cancer risk for some men, and doesn’t require a visit to the GP The test gave fewer false ...

DEAR DR. ROACH: I’m writing to you about an elderly patient who is currently 96 years old. For the last three years, his PSA score for his prostate has hovered around 30 ng/ml. He initially received ...

For the men with the highest risk score, the study found this to be a better tool than the blood test which measures levels of a protein called prostate-specific antigen (PSA), which can be elevated ...